¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°æºÏ´ëÇб³º´¿ø Ç÷°ü±âÇü ½ÉÆ÷Áö¾ö 2021 : 2021-06-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°æºÏ´ëÇб³º´¿ø Ç÷°ü±âÇü ½ÉÆ÷Áö¾ö 2021 : 2021-06-12
±³À°ÀÏÀÚ : 2021-06-12
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà (*¿ÀÇÁ¶óÀÎ : °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç )  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) °æºÏ´ëÇб³º´¿ø Ç÷°ü±âÇü ½ÉÆ÷Áö¾ö 2021
ÁÖÃÖ±â°ü : °æºÏ´ëÇб³º´¿ø
´ã´çÀÚ : Á¤È£À±
¿¬¶ôó : 053-200-5685  
À̸ÞÀÏ : hy-chung@knu.ac.kr      
±³À°Á¾·ù : ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, ¼ºÇü¿Ü°ú, ÇǺΰú, ¿µ»óÀÇÇаú, ÇÙÀÇÇаú      
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í *Âü°¡¿¹»óÀοø : ¿ÀÇÁ¶óÀÎ 30¸í, ¿Â¶óÀÎ 40¸í *¼¼ºÎ¼ö°­·á : Àü¹®ÀÇ(»çÀü 2¸¸, ÇöÀå 3¸¸)/Àü°øÀÇ(»çÀü 1¸¸, ÇöÀå 2¸¸)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 10:00~10:10 Opening remarks  Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 10:10~10:30 Session¥°. Updated Basic concept 1. ISSVA Classification 2018  Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 10:30~10:50 Session¥°. Updated Basic concept 2. Basic Pathophysiology of vascular anomalies  È«Á¾¿ø(¿¬¼¼´ë ¼ºÇü¿Ü°ú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 10:50~11:10 Session¥°. Updated Basic concept 3. Basic Radiology Guide to Vascular Anomalies  ÀÌÁ¾¹Î(°æºÏ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 11:10~11:27 Session ¥±. Uncommon Tumors – Tufted angioma / Kaposiform hemangioendothelioma 5. Clinical & Pathological Features  º¯Áö¿ø(ÀÎÇÏ´ë ÇǺΰú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 11:27~11:44 Session ¥±. Uncommon Tumors – Tufted angioma / Kaposiform hemangioendothelioma 6. Radiologic Manifestations  Â÷Áß±Ù(°æºÏ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 11:44~12:00 Session ¥±. Uncommon Tumors – Tufted angioma / Kaposiform hemangioendothelioma 7. Medical Therapies  ±èÁöÀ±(°æºÏ´ë ¼Ò¾Æû¼Ò³â°ú) 
½Ä»ç 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 12:00~12:50 Lunch  () 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 12:50~13:07 Session ¥². Provisionally unclassified vascular anomalies 1- Angiokeratoma / Verrucous Hemangioma 9. Clinical & Pathological Features  À̼®Á¾(°æºÏ´ë ÇǺΰú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 13:07~13:24 Session ¥². Provisionally unclassified vascular anomalies 1- Angiokeratoma / Verrucous Hemangioma 10. Radiologic Manifestations  È«ÁöÈÆ(°æºÏ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 13:24~13:40 Session ¥². Provisionally unclassified vascular anomalies 1- Angiokeratoma / Verrucous Hemangioma 11. Surgical Management  Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 13:40~13:57 Session ¥³. Provisionally unclassified vascular anomalies 2-Intramuscular LVM(IMLVM)/PTEN (type) hamartoma of soft tissue / ¡°angiomatosis¡± of soft tissue (PHOST) / Fibro adipose vascular anomaly (FAVA) / Intramuscular hemangioma 13. Clinical and Pathological Findings  À̼®Á¾(°æºÏ´ë ÇǺΰú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 13:57~14:14 Session ¥³. Provisionally unclassified vascular anomalies 2-Intramuscular LVM(IMLVM)/PTEN (type) hamartoma of soft tissue / ¡°angiomatosis¡± of soft tissue (PHOST) / Fibro adipose vascular anomaly (FAVA) / Intramuscular hemangioma 14. Radiologic Manifestations  ÀÌÁ¾¹Î(°æºÏ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 14:14~14:30 Session ¥³. Provisionally unclassified vascular anomalies 2-Intramuscular LVM(IMLVM)/PTEN (type) hamartoma of soft tissue / ¡°angiomatosis¡± of soft tissue (PHOST) / Fibro adipose vascular anomaly (FAVA) / Intramuscular hemangioma 15. Management  Á¤È£À±(°æºÏ´ë ¼ºÇü¿Ü°ú) 
È޽Ġ06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 14:30~14:40 Coffee break  () 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 14:40~14:53 Session ¥´. Vascular malformations associated with other anomalies – Klippel-Trenaunay syndrome / Parkes Weber syndrome 17. Clinical Features  Çã½Â(°æºÏ´ë Ç÷°ü¿Ü°ú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 14:53~15:06 Session ¥´. Vascular malformations associated with other anomalies – Klippel-Trenaunay syndrome / Parkes Weber syndrome 18. Radiologic Manifestations  ÀÌ»ó¿±(°æºÏ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 15:06~15:20 Session ¥´. Vascular malformations associated with other anomalies – Klippel-Trenaunay syndrome / Parkes Weber syndrome 19. Management  ·ùÁ¤¿±(°æºÏ´ë ¼ºÇü¿Ü°ú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 15:20~15:45 Session ¥µ. Updated Diagnosis & management of vascular anomalies 21. Diagnosis of Vascular Anomalies in Nuclear Medicine  ¾Èº´Ã¶(°æºÏ´ë ÇÙÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 15:45~16:10 Session ¥µ. Updated Diagnosis & management of vascular anomalies 22. Rehabilitation in Vascular Anomalies  ¹ÚÀºÈñ(°æºÏ´ë ÀçÈ°ÀÇÇаú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 16:10~16:35 Session ¥µ. Updated Diagnosis & management of vascular anomalies 23. Topical Rapamycin (Sirolimus) Treatment  ±èÈƼö(ºÎ»ê´ë ÇǺΰú) 
±³À°½Ã°£ 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 16:35~17:00 Session ¥µ. Updated Diagnosis & management of vascular anomalies 24. Recent Medical Therapies in Vascular Anomalies  ÀÓ¿¬Á¤(Ãæ³²´ë ¼Ò¾Æû¼Ò³â°ú) 
Åä·Ð 06-12 °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿Àε¿ Ä·ÆÛ½º Áß¾Ó°­´ç 17:00~17:30 Session ¥¶. Self assessment (Diagnosis & Management) 26. Case presentation & Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °æºÏ´ëÇб³º´¿ø Ç÷°ü±âÇü ½ÉÆ÷Áö¾ö 2021 : 2021-06-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇѹα¹ ÀÇ·á°è¿¡¼­ ÀÔ¿øÀÇÇаúÀÇ ¿ªÇÒ ¹× Àü¸Á : 2021-06-12
´ÙÀ½±Û 2021 ¼ö¸éÈ£ÈíÀå¾Ö ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2021-06-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 35 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 32 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 35 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 41 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 35 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 26 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 10 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 24 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 13 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 11 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 28 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 15 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 25 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 18 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷